REG - Rentokil Initial PLC - Issue of Debt

Rentokil InitialAnnouncement

Yesterday 14:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250428:nRSb4756Ga&default-theme=true

RNS Number : 4756G  Rentokil Initial PLC  28 April 2025

 

28 April 2025

RENTOKIL INITIAL PLC

BENCHMARK USD ISSUANCE OF $750 MILLION 5.000% NOTES DUE 2030 AND

$500 MILLION 5.625% NOTES DUE 2035

On 28 April 2025, Rentokil Terminix Funding, LLC, a wholly-owned finance
subsidiary of Rentokil Initial plc (the "Company"), issued its inaugural
senior, unsecured $750 million 5.000% Notes due 2030 and $500 million 5.625%
Notes due 2035 (together, the "Notes") guaranteed by the Company and offered
in the United States only to qualified institutional buyers pursuant to Rule
144A under the U.S. Securities Act of 1933, as amended (the "Securities Act")
and outside the United States pursuant to Regulation S under the Securities
Act. The Company intends to use approximately $700 million of the net proceeds
from the Notes issuance to repay a term loan which otherwise matures in
October 2025, and otherwise for general corporate purposes.

Application has been made to list the Notes on the Official List of the Irish
Stock Exchange plc trading as Euronext Dublin ("Euronext Dublin") and to trade
the Notes on the Global Exchange Market of Euronext Dublin.

 

 

Enquiries:

Investors / Analysts: Peter Russell, Rentokil Initial plc, + 44 7795 166506

Media: Malcolm Padley, Rentokil Initial plc, +44 7788 978199

 

 

DISCLAIMER

The information contained herein shall not constitute or form part of any
offer to sell or solicitation of an offer to buy the securities referred to
herein. The Notes have not been and will not be registered under the
Securities Act, or any state securities laws and, unless so registered, may
not be offered or sold within the United States or to, or for the account or
the benefit of, US persons, as defined in Regulation S under the Securities
Act, except pursuant to an exemption from or in a transaction not subject to
the registration requirements of the Securities Act and in compliance with any
applicable state securities laws.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IODSEDFDAEISEFL